Literature DB >> 21821378

Patterns in admission delays to outpatient methadone treatment in the United States.

Jan Gryczynski1, Robert P Schwartz, David S Salkever, Shannon Gwin Mitchell, Jerome H Jaffe.   

Abstract

Waiting lists for methadone treatment have existed in many U.S. communities, but little is known nationally about what patient and service system factors are related to admission delays that stem from program capacity shortfalls. Using a combination of national data sources, this study examined patterns in capacity-related admission delays to outpatient methadone treatment in 40 U.S. metropolitan areas (N = 28,920). Patient characteristics associated with admission delays included racial/ethnic minority status, lower education, criminal justice referral, prior treatment experience, secondary cocaine or alcohol use, and co-occurring psychiatric problems. Injection drug users experienced fewer delays, as did self-pay patients and referrals from health care and addiction treatment providers. Higher community-level utilization of methadone treatment was associated with delay, whereas delays were less common in communities with higher utilization of alternative modalities. These findings highlight potential disparities in timely admission to outpatient methadone treatment. Implications for improving treatment access and service system monitoring are discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821378      PMCID: PMC3205308          DOI: 10.1016/j.jsat.2011.06.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  49 in total

1.  Randomized trial of drug abuse treatment-linkage strategies.

Authors:  James L Sorensen; Carmen L Masson; Kevin Delucchi; Karl Sporer; Paul G Barnett; Fumi Mitsuishi; Christine Lin; Yong Song; TeChieh Chen; Sharon M Hall
Journal:  J Consult Clin Psychol       Date:  2005-12

2.  Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.

Authors:  Steffanie A Strathdee; Erin P Ricketts; Steven Huettner; Lee Cornelius; David Bishai; Jennifer R Havens; Peter Beilenson; Charles Rapp; Jacqueline J Lloyd; Carl A Latkin
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

Review 3.  When can group level clustering be ignored? Multilevel models versus single-level models with sparse data.

Authors:  P Clarke
Journal:  J Epidemiol Community Health       Date:  2008-08       Impact factor: 3.710

4.  Predicting drug treatment entry among treatment-seeking individuals.

Authors:  Y I Hser; M Maglione; M L Polinsky; M D Anglin
Journal:  J Subst Abuse Treat       Date:  1998 May-Jun

5.  Facilitating treatment entry among out-of-treatment injection drug users.

Authors:  R E Booth; C Kwiatkowski; M Y Iguchi; F Pinto; D John
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 6.  Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment.

Authors:  D C Lewis
Journal:  J Addict Dis       Date:  1999

7.  The effectiveness of outreach case management in re-enrolling discharged methadone patients.

Authors:  Donna M Coviello; Dave A Zanis; Susan A Wesnoski; Arthur I Alterman
Journal:  Drug Alcohol Depend       Date:  2006-05-03       Impact factor: 4.492

8.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

9.  Interim methadone treatment: impact on arrests.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Timothy W Kinlock; Michael S Gordon; Sharon M Kelly; Monique E Wilson; Ashraf Ahmed
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

10.  Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.

Authors:  Peter D Friedmann; Stephenie C Lemon; Michael D Stein; Thomas A D'Aunno
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

View more
  26 in total

1.  Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Sharon M Kelly; Kevin E O'Grady; Jerome H Jaffe; Yngvild K Olsen; Robert P Schwartz
Journal:  J Drug Issues       Date:  2014-01

2.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

3.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

4.  Mindfulness-based relapse prevention with racial and ethnic minority women.

Authors:  Katie Witkiewitz; Brenna L Greenfield; Sarah Bowen
Journal:  Addict Behav       Date:  2013-08-26       Impact factor: 3.913

5.  Failure to get into substance abuse treatment.

Authors:  Dennis G Fisher; Grace L Reynolds; Laura H D'Anna; David W Hosmer; Kholoud Hardan-Khalil
Journal:  J Subst Abuse Treat       Date:  2016-11-16

Review 6.  Adapting Screening, Brief Intervention, and Referral to Treatment for Alcohol and Drugs to Culturally Diverse Clinical Populations.

Authors:  Jennifer K Manuel; Derek D Satre; Janice Tsoh; Gina Moreno-John; Jacqueline S Ramos; Elinore F McCance-Katz; Jason M Satterfield
Journal:  J Addict Med       Date:  2015 Sep-Oct       Impact factor: 3.702

7.  Pharmacotherapy for opioid addiction in community corrections.

Authors:  Robert P Schwartz; Mary M Mitchell; Kevin E O'Grady; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Michael S Gordon; Jerome H Jaffe
Journal:  Int Rev Psychiatry       Date:  2018-12-06

8.  Justice Involvement and Treatment Use Among Rural Veterans.

Authors:  Andrea K Finlay; Alex H S Harris; Joel Rosenthal; Jessica Blue-Howells; Sean Clark; Bessie Flatley; Christine Timko
Journal:  Rural Ment Health       Date:  2018-01

9.  Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.

Authors:  Jan Gryczynski; Jerome H Jaffe; Robert P Schwartz; Kristi A Dušek; Nishan Gugsa; Cristin L Monroe; Kevin E O'Grady; Yngvild K Olsen; Shannon Gwin Mitchell
Journal:  Am J Addict       Date:  2013 May-Jun

10.  Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.

Authors:  Rachel M Burns; Rosalie L Pacula; Sebastian Bauhoff; Adam J Gordon; Hollie Hendrikson; Douglas L Leslie; Bradley D Stein
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.